Wall Street Associates’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-35,200
| Closed | -$2.46M | – | 213 |
|
|
2016
Q3 | $2.46M | Hold |
35,200
| – | – | 0.84% | 42 |
|
|
2016
Q2 | $1.37M | Hold |
35,200
| – | – | 0.55% | 73 |
|
|
2016
Q1 | $1.43M | Hold |
35,200
| – | – | 0.59% | 72 |
|
|
2015
Q4 | $3.12M | Sell |
35,200
-84,700
| -71% | -$7.51M | 0.88% | 22 |
|
|
2015
Q3 | $8.88M | Sell |
119,900
-21,400
| -15% | -$1.58M | 1.7% | 3 |
|
|
2015
Q2 | $11.4M | Sell |
141,300
-20,800
| -13% | -$1.68M | 1.08% | 15 |
|
|
2015
Q1 | $6.79M | Sell |
162,100
-37,900
| -19% | -$1.59M | 0.64% | 52 |
|
|
2014
Q4 | $3.1M | Hold |
200,000
| – | – | 0.3% | 104 |
|
|
2014
Q3 | $2.53M | Hold |
200,000
| – | – | 0.26% | 114 |
|
|
2014
Q2 | $2.87M | Hold |
200,000
| – | – | 0.25% | 128 |
|
|
2014
Q1 | $2.55M | Buy |
+200,000
| New | +$2.55M | 0.21% | 145 |
|